In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1735 News Items found
Article
MSK medical oncologist Komal Jhaveri.
Imlunestrant Stops Progression of ER+, HER2- Advanced Breast Cancer That Resists Standard Therapy

Read about a new treatment for people with some ER+, HER2- advanced breast cancers.
Support
Nurse practitioner Amy Devigne
MSK Program Keeps a Close Watch on Long-Term Lung Cancer Survivors

An MSK program helps lung cancer survivors stay healthy following successful treatment for their disease.
Article
Logo from the annual meeting of the American Society of Hematology.
New MSK Research on Leukemia, Lymphoma, and Myeloma Presented at 2024 Conference

Read highlights of research presented by MSK scientists at the annual ASH meeting.
MSK multiple myeloma specialist Urvy Shah
Diets for MGUS, Smoldering Myeloma, and Multiple Myeloma: Q&A With MSK Cancer and Nutrition Experts

Learn how eating a plant-based diet may prevent MGUS and smoldering myeloma from developing into multiple myeloma, according to MSK research.
Meryl Jacobs poses with her husband and grandkids
FDA Approves Zenocutuzumab for Pancreatic and Lung Cancers With NRG1 Fusions 

The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small cell lung cancer with an alteration called an NRG1 gene fusion, based on a phase 2 clinical trial led by an MSK investigator.
MSK patient Michael Simien poses with his bicycle in front of a fountain in New York City
This Remarkable MSK Patient Is Living With Two Kinds of Stage 4 Cancer

Learn how it's possible to stay active even with two types of advanced cancer — lung cancer and mantle cell lymphoma — thanks to innovative treatments at MSK.
At Work
Ivan Maillard
A ‘Matchmaker’ Between the Lab and the Clinic: At Work With Ivan Maillard

A passion for both science and the humanities has informed the life and career of Dr. Ivan Maillard, who was recently selected to lead the Division of Hematologic Malignancies at MSK.
Tammela Lab
Cancer Risk Declines in Old Age, New MSK Research Helps Explain Why

A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for treating patients in different age groups.
Jhalene Mundin
How MSK Cares for a Young Woman Living With Stage 4 EGFR Lung Cancer

Learn how a young woman diagnosed with stage 4 non-small cell lung cancer had many treatment options because she came to MSK first.
In the Clinic
MSK thoracic surgeon Alexis Chidi
Six Things You Need to Know About Lung Cancer Screening

Find out why people at risk of lung cancer are not getting screened and why they should.